Lenalidomide maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma

  • Technology appraisal guidance
  • TA680
  • Published: 

History

Expected publication

Final draft guidance

Draft guidance: 1

Invitation to participate

Multiple myeloma - lenalidomide: equality impact assessment

Multiple myeloma - lenalidomide: comments on the provisional matrix - May 2012

Multiple myeloma - lenalidomide: response to consultee and commentator comments on the draft scope - May 2012

Multiple myeloma - lenalidomide: final matrix of consultees and commentators - May 2012

Multiple myeloma - lenalidomide: final scope - May 2012

Multiple myeloma - lenalidomide: draft scope for consultation (pre-referral) - March 2011

Multiple myeloma - lenalidomide: provisional matrix (pre-referral) - March 2011